'These findings support the continued development of mRNA-1893 against Zika virus, which was well tolerated at all evaluated dose levels and induced strong Zika virus-specific serum nAb responses after two doses, regardless of baseline flavivirus serostatus.'

#Zika #immunology #Virology #mRNA #Vaccine

https://www.sciencedirect.com/science/article/abs/pii/S1473309922007642